Southern Cross University clinical trials

SCU research partner Ki-Whole Enterprises are investigating the use of a natural marine product on body composition, muscular strength and inflammation in women.

They are seeking non-smoking generally healthy volunteers (aged 40-65 years) who are pre-menopausal or post-menopausal for our latest 26-week clinical trial. 

Maintaining a healthy body composition, particularly skeletal muscle mass, is a critical factor in successful ageing. Changes to our body composition can begin during the fourth decade of life; supplements that are found to help maintain a healthy body composition could play an important role in healthy ageing along with a healthy lifestyle.

Participants who have met all inclusion criteria will attend three clinical appointments at the Southern Cross University’s Lismore campus. Participants will receive an assessment of their body composition and muscular strength, along with a measure of their blood fatty acids and several inflammation markers.

This trial will NOT suit those with a shellfish allergy. 

This clinical trial has approval from the Southern Cross University Human Research Ethics Committee (ECN: 2020-117).

If you are interested in participating, please contact the clinical trial coordinator Shelley Robinson. 

Email marine2021@scu.edu.au

Register now

Southern Cross University researchers are investigating the efficacy of an over-the-counter botanical cannabidiol (CBD) product to help with sleep disturbances in women and men.

They are seeking generally healthy individuals aged 18-65 years old, who have self-reported poor sleep. This may include people who have difficulty initiating sleep, maintaining sleep, or are waking earlier than desired. Participants can partake in the trial in Melbourne, Sydney, Brisbane or Lismore. Each participant will partake in the trial for 10 weeks.

This trial involves participation in a randomized placebo-controlled clinical trial, which means participants will receive either a placebo or an active product. A placebo is a treatment which is designed to have no therapeutic value, but is similar in look, taste and smell to the other treatment being tested.

This clinical trial has approval from the Southern Cross University Human Research Ethics Committee, SCU HREC number: 2021/031

For more information about the clinical trial or to check if you are eligible to participate, please visit the below website. The patient information sheet can be obtained by contacting the lead researcher, Dr Janet Schloss.

Email ncnmtrials@scu.edu.au,
or call 0436 101 306 or 02 6626 9255

Check your eligibility here

Following several successful studies, Ki-Whole Enterprises is continuing to investigate the effects of a natural marine product on osteoarthritis.

They are seeking non-smoking men (aged 45–75 years of age) who have osteoarthritis of the knee, but are otherwise healthy.

Participants who have met the inclusion criteria will complete all required documentation, including research questionnaires via an online format during the 6-week study. Study participants will NOT be required to attend in person. 

This clinical trial has approval from the Southern Cross University Human Research Ethics Committee (ECN-2021-045).

If you are interested in participating, please contact the clinical trial coordinator Shelley Robinson via email or by clicking on the 'Register now' button below.

Email men2021@scu.edu.au 

Register now